Jill Kolesar, PharmD, MS, BCPS, FCCP
University Research Professor
Dr. Jill Kolesar is Professor of Pharmacy at the University of Kentucky and holds administrative positions at the Markey Cancer Center as the Director of the Precision Medicine Center, Co-Chair of the Molecular Tumor Board, and the Co-Leader of the Developmental Therapeutics Program. She is a member of the Graduate Faculty in the College of Pharmacy, a member of the Markey Cancer Center and holds a joint appointment in Internal Medicine in the College of Medicine.
Dr. Kolesar contributes substantial and sustained professional service to both the National Cancer Institute (NCI) and several pharmacy organizations. Serving on both the Early Phase and Cancer Prevention Central IRBs (CIRBs), multiple NCI study sections, and the Cancer Therapy and Evaluation Program (CTEP) Pharmacology task force. Jill is a board certified Pharmacotherapy Specialist and is a past President of the American College of Clinical Pharmacy (ACCP).
Dr. Kolesar’s research focuses on the drug development of anticancer agents with an emphasis on targeted therapies and biomarkers. She has authored more than 300 abstracts, research articles, and book chapters, and as a principal investigator she has received more than $5 million in research funding from the NCI, American Cancer Society and other sources.
- Precision medicine
- Clinical pharmacology
- Cancer drug development
Co-Leader, Translational Oncology Research Program
Director Precision Medicine Program, Markey Cancer Center
BS, University of Wisconsin
PharmD, University of Texas Health Science Center
MS in Genetic Epidemiology, University of Wisconsin